WFA
FLGT icon

WMG Financial Advisors’s Fulgent Genetics FLGT Stock Holding History

WMG Financial Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,162
Closed -$228K – 143
2022
Q2 		$228K Sell
4,162
-512
-11% -$28.1K 0.2% 119
2022
Q1 		$290K Sell
4,674
-288
-6% -$19K 0.21% 117
2021
Q4 		$499K Buy
+4,962
New +$436K 0.39% 65

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WMG Financial Advisors's FLGT Position: Q3 2022 in Review

WMG Financial Advisors sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 4,162 shares — an estimated $228K sold.

WMG Financial Advisors first reported a position in FLGT in Q4 2021 and held it in 3 quarters. The position peaked at $499K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • WMG Financial Advisors reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • WMG Financial Advisors sold 4,162 Fulgent Genetics shares in Q3 2022, an estimated $228K.
  • WMG Financial Advisors first reported a position in Fulgent Genetics in Q4 2021 and held it in 3 quarters.
  • WMG Financial Advisors's Fulgent Genetics position peaked at $499K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on WMG Financial Advisors's 13F filing for Q3 2022, filed 18 Oct 2022.